Thursday, QIAGEN N.V. (QGEN) said that it has priced its offering of 27.5 million common shares at a price of US$20.25 per share for gross proceeds of about US$557 million.
The company plans to use the net proceeds of this Offering to fund the acquisition of DxS Ltd. announced on September 22, 2009 and potential future acquisitions, to strengthen its balance sheet and for general corporate purposes.
For comments and feedback: editorial@rttnews.com